245 related articles for article (PubMed ID: 27317047)
1. Investigating strain dependency in the production of aromatic compounds in Saccharomyces cerevisiae.
Suástegui M; Guo W; Feng X; Shao Z
Biotechnol Bioeng; 2016 Dec; 113(12):2676-2685. PubMed ID: 27317047
[TBL] [Abstract][Full Text] [Related]
2. Pathway engineering for the production of heterologous aromatic chemicals and their derivatives in Saccharomyces cerevisiae: bioconversion from glucose.
Gottardi M; Reifenrath M; Boles E; Tripp J
FEMS Yeast Res; 2017 Jun; 17(4):. PubMed ID: 28582489
[TBL] [Abstract][Full Text] [Related]
3. An Engineered Aro1 Protein Degradation Approach for Increased
Pyne ME; Narcross L; Melgar M; Kevvai K; Mookerjee S; Leite GB; Martin VJJ
Appl Environ Microbiol; 2018 Sep; 84(17):. PubMed ID: 29934332
[TBL] [Abstract][Full Text] [Related]
4. Biosensor-Enabled Directed Evolution to Improve Muconic Acid Production in Saccharomyces cerevisiae.
Leavitt JM; Wagner JM; Tu CC; Tong A; Liu Y; Alper HS
Biotechnol J; 2017 Oct; 12(10):. PubMed ID: 28296355
[TBL] [Abstract][Full Text] [Related]
5. An expanded enzyme toolbox for production of cis, cis-muconic acid and other shikimate pathway derivatives in Saccharomyces cerevisiae.
Brückner C; Oreb M; Kunze G; Boles E; Tripp J
FEMS Yeast Res; 2018 Mar; 18(2):. PubMed ID: 29462295
[TBL] [Abstract][Full Text] [Related]
6. Plasmid-encoded biosynthetic genes alleviate metabolic disadvantages while increasing glucose conversion to shikimate in an engineered Escherichia coli strain.
Rodriguez A; Martínez JA; Millard P; Gosset G; Portais JC; Létisse F; Bolivar F
Biotechnol Bioeng; 2017 Jun; 114(6):1319-1330. PubMed ID: 28186321
[TBL] [Abstract][Full Text] [Related]
7. Metabolic engineering of a tyrosine-overproducing yeast platform using targeted metabolomics.
Gold ND; Gowen CM; Lussier FX; Cautha SC; Mahadevan R; Martin VJ
Microb Cell Fact; 2015 May; 14():73. PubMed ID: 26016674
[TBL] [Abstract][Full Text] [Related]
8. Iterative optimization of xylose catabolism in Saccharomyces cerevisiae using combinatorial expression tuning.
Latimer LN; Dueber JE
Biotechnol Bioeng; 2017 Jun; 114(6):1301-1309. PubMed ID: 28165133
[TBL] [Abstract][Full Text] [Related]
9. Production of para-aminobenzoic acid from different carbon-sources in engineered Saccharomyces cerevisiae.
Averesch NJ; Winter G; Krömer JO
Microb Cell Fact; 2016 May; 15():89. PubMed ID: 27230236
[TBL] [Abstract][Full Text] [Related]
10. Engineering and systems-level analysis of Saccharomyces cerevisiae for production of 3-hydroxypropionic acid via malonyl-CoA reductase-dependent pathway.
Kildegaard KR; Jensen NB; Schneider K; Czarnotta E; Özdemir E; Klein T; Maury J; Ebert BE; Christensen HB; Chen Y; Kim IK; Herrgård MJ; Blank LM; Forster J; Nielsen J; Borodina I
Microb Cell Fact; 2016 Mar; 15():53. PubMed ID: 26980206
[TBL] [Abstract][Full Text] [Related]
11. Toward "homolactic" fermentation of glucose and xylose by engineered Saccharomyces cerevisiae harboring a kinetically efficient l-lactate dehydrogenase within pdc1-pdc5 deletion background.
Novy V; Brunner B; Müller G; Nidetzky B
Biotechnol Bioeng; 2017 Jan; 114(1):163-171. PubMed ID: 27426989
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a yeast platform strain for production of p-coumaric acid through metabolic engineering of aromatic amino acid biosynthesis.
Rodriguez A; Kildegaard KR; Li M; Borodina I; Nielsen J
Metab Eng; 2015 Sep; 31():181-8. PubMed ID: 26292030
[TBL] [Abstract][Full Text] [Related]
13. Innovating a Nonconventional Yeast Platform for Producing Shikimate as the Building Block of High-Value Aromatics.
Gao M; Cao M; Suástegui M; Walker J; Rodriguez Quiroz N; Wu Y; Tribby D; Okerlund A; Stanley L; Shanks JV; Shao Z
ACS Synth Biol; 2017 Jan; 6(1):29-38. PubMed ID: 27600996
[TBL] [Abstract][Full Text] [Related]
14. Engineering the shikimate pathway for biosynthesis of molecules with pharmaceutical activities in E. coli.
Jiang M; Zhang H
Curr Opin Biotechnol; 2016 Dec; 42():1-6. PubMed ID: 26921705
[TBL] [Abstract][Full Text] [Related]
15. Improved production of N-acetylglucosamine in Saccharomyces cerevisiae by reducing glycolytic flux.
Lee SW; Oh MK
Biotechnol Bioeng; 2016 Nov; 113(11):2524-8. PubMed ID: 27217143
[TBL] [Abstract][Full Text] [Related]
16. Multilevel engineering of the upstream module of aromatic amino acid biosynthesis in Saccharomyces cerevisiae for high production of polymer and drug precursors.
Suástegui M; Yu Ng C; Chowdhury A; Sun W; Cao M; House E; Maranas CD; Shao Z
Metab Eng; 2017 Jul; 42():134-144. PubMed ID: 28625755
[TBL] [Abstract][Full Text] [Related]
17. Metabolic engineering of muconic acid production in Saccharomyces cerevisiae.
Curran KA; Leavitt JM; Karim AS; Alper HS
Metab Eng; 2013 Jan; 15():55-66. PubMed ID: 23164574
[TBL] [Abstract][Full Text] [Related]
18. Biosynthesis of cis,cis-muconic acid and its aromatic precursors, catechol and protocatechuic acid, from renewable feedstocks by Saccharomyces cerevisiae.
Weber C; Brückner C; Weinreb S; Lehr C; Essl C; Boles E
Appl Environ Microbiol; 2012 Dec; 78(23):8421-30. PubMed ID: 23001678
[TBL] [Abstract][Full Text] [Related]
19. Enhanced d-lactic acid production by recombinant Saccharomyces cerevisiae following optimization of the global metabolic pathway.
Yamada R; Wakita K; Mitsui R; Ogino H
Biotechnol Bioeng; 2017 Sep; 114(9):2075-2084. PubMed ID: 28475210
[TBL] [Abstract][Full Text] [Related]
20. Biotechnological production of aromatic compounds of the extended shikimate pathway from renewable biomass.
Lee JH; Wendisch VF
J Biotechnol; 2017 Sep; 257():211-221. PubMed ID: 27871872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
